Purchases and Sales Made in Q3 2023 in X4 Pharmaceuticals, Inc (XFOR)
This table provides information about the institutional ownership of X4 Pharmaceuticals, Inc (XFOR) during Q3 2023. The information is specifically focused on institutions that hold shares of X4 Pharmaceuticals, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-136K- 56.42% |
$140K - $275K
|
105K
$35.8K
|
|
|
Nov 13, 2023
Q3 2023
|
Monashee Investment Management LLC
Boston, MA |
SELL
|
- |
-146K- 25.41% |
$150K - $294K
|
427K
$145K
|
|
|
Nov 01, 2023
Q3 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-213K- 94.14% |
$220K - $431K
|
13.3K
$4.52K
|
|
|
Nov 14, 2023
Q3 2023
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-277K- 8.09% |
$285K - $560K
|
3.15M
$1.07M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-285K- 85.17% |
$293K - $575K
|
49.6K
$16.9K
|
|
|
Nov 14, 2023
Q3 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-346K- 96.28% |
$356K - $698K
|
13.4K
$4.54K
|
|
|
Nov 14, 2023
Q3 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-398K- 40.42% |
$410K - $803K
|
586K
$199K
|
|
|
Nov 14, 2023
Q3 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-620K- 20.83% |
$639K - $1.25M
|
2.36M
$801K
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-691K- 98.17% |
$712K - $1.4M
|
12.9K
$4.38K
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-938K- 10.32% |
$967K - $1.9M
|
8.16M
$2.77M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.28M- 41.48% |
$1.31M - $2.58M
|
1.8M
$612K
|
|
|
Nov 14, 2023
Q3 2023
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-2.97M- 78.76% |
$3.06M - $5.99M
|
800K
$272K
|